James W. Green - Nov 30, 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Chief Executive Officer, Director
Signature
/s/ David Sirois, by power of attorney
Stock symbol
HBIO
Transactions as of
Nov 30, 2022
Transactions value $
$75,300
Form type
4
Date filed
12/2/2022, 03:01 PM
Previous filing
Aug 18, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Purchase $36.2K +15K +0.67% $2.41 2.26M Nov 30, 2022 Direct F1, F2
transaction HBIO Common Stock Purchase $39.2K +15K +0.66% $2.61 2.28M Dec 1, 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.31 to $2.45, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Includes (a) the shares described in footnote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,307,205 shares of common stock beneficially owned by the Reporting Person.
F3 This transaction was executed in multiple trades at prices ranging from $2.55 to $2.70, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Includes (a) the shares and awards described in footnote (2) above, and (b) the shares purchased in the transaction described in footnote (3) above.